London Daily
Focus on the big picture.
Friday, Dec 09, 2022
LondOn!
Add Your News
Radio
BioNTech
China’s Xinjiang sees protests against COVID lockdown
Local authorities to partially and progressively ease lockdown in ‘low risk’ areas, CNN reports.
Retired head of vaccine R&D at Pfizer about COVID vaccines: “We flew the aeroplane while we were still building it”
Recently retired head of vaccine R&D at Pfizer, Kathrin Jansen, discusses the lightning speed development of SARS-CoV-2 vaccines — and the implications for vaccine platforms. Recently retired head of vaccine R&D at Pfizer, Kathri...
Xi opposing nuclear weapons in Ukraine was reason enough to visit China, Scholz says
German Chancellor Olaf Scholz, who was heavily criticised for a trip to Beijing this week, said on Saturday his and Chinese President Xi Jinping's joint statement opposing the use of nuclear weapons in Ukraine had been reason enough for ...
China to maintain zero-COVID policy
Measures should be fine-tuned to better help vulnerable people, officials say.
China’s Xi warns Putin not to use nuclear arms in Ukraine
Chinese leader makes the call during a visit by German Chancellor Olaf Scholz.
EU prosecutor’s office opens investigation into COVID vaccine purchases
The EPPO didn’t specify who was being investigated, or which of the EU’s vaccine contracts are under scrutiny.
EU stonewalls over von der Leyen’s role in multibillion-euro Pfizer vaccine deal
European Court of Auditors accuses Commission of refusing to release details of how the bloc’s biggest vaccine contract was negotiated.
EU regulator approves Omicron vaccines
The European Union’s drug regulator has recommended the use of two Omicron-tailored vaccines developed by the Pfizer-BioNTech partnership and Moderna Inc ahead of a fresh booster programme this fall across the continent.
WHO: New COVID cases, deaths keep falling nearly everywhere
The number of new coronavirus cases and deaths reported globally continued to fall nearly everywhere in the world in what the World Health Organization described as a “welcome decline” at a media briefing on Wednesday.
Britain approves Novavax COVID shot for 12-17 year-olds
Britain's medicines regulator on Friday approved Novavax's (NVAX.O) COVID-19 vaccine for children aged between 12 and 17 years.
Moderna Sues Pfizer Over Covid Vaccine
In a statement issued on Friday, Moderna says Pfizer and BioNTech infringed on its patents in developing their vaccine shots.
Pfizer CEO Albert Bourla tests positive for Covid-19 after 4 jabs
Albert Bourla, CEO of drugmaker Pfizer, has tested positive for Covid-19 and has "very mild symptoms," he said in a tweet on Monday.
Biden still testing positive after rebound Covid-19 case but 'continues to feel well,' White House says
President Joe Biden is continuing to isolate at the White House on Sunday after testing positive for a rebound case of Covid-19 Saturday morning, White House physician Kevin O'Connor wrote in a letter Sunday that was released by the Whit...
NFT of mRNA vaccine research to go on sale
A new NFT digital asset from the University of Pennsylvania showcases pivotal mRNA research that could lead to life-changing vaccines for COVID-19 and beyond.
Covid vaccines for kids under 5 are nearly here. Here’s what you need to know.
Both Pfizer-BioNTech and Moderna vaccines will soon be available for all kids older than 6 months.
Only 7% of 5-11s in England have had Covid jab as parents hesitate
Six weeks after start of vaccine rollout, fraction of young children have had first dose as parents question usefulness
Pfizer accused of Covid profiteering as first-quarter sales hit $26bn
Pharma firm criticised over pricing and for keeping monopoly control over vaccine and new Paxlovid pill
Unvaccinated children hospitalized at twice the rate during Omicron surge -U.S. study
Hospitalization rates for unvaccinated children ages 5 to 11 were twice as high as among those who were vaccinated during the record COVID-19 surge caused by the Omicron variant, according to a U.S. study released on Tuesday.
Fourth shot protects against severe Omicron outcomes; COVID may increase risk of rare eye blood clots
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
China's Health System Faces Raft Of Challenges As Omicron Hits
Chinese vaccines have shown a lower rate of efficacy in studies compared with many foreign jabs.
Can America fix Europe's gas problem?
North Atlantic shipping lanes are going to be very busy this year as an armada of US natural gas shipments heads to Europe, helping the continent to reduce its reliance on Russian energy following the invasion of Ukraine.
Hong Kong Covid crisis: why is the death rate so high?
Low vaccination rates among the elderly, low rates of prior infection and an overwhelmed healthcare system have contributed to create the perfect storm
EU Approves Moderna Covid Vaccine For Children 6-11
The regulator has so far approved 5 jabs for use in the EU: Pfizer and Moderna, which use messenger RNA technology, AstraZeneca and Johnson & Johnson.
Six African countries to begin making mRNA vaccines as part of WHO scheme
Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia first countries to be assisted by global mRNA hub
Load More
×
London Daily
Add Your News
0:00
×
